Ligand Pharmaceuticals NASDAQ: LGND reported second-quarter 2026 results marked by higher royalty re

Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript

Arrowstreet Capital Limited Partnership reduced its position in Ligand Pharmaceuticals Incorporated

Ashford Capital Management Inc. reduced its position in shares of Ligand Pharmaceuticals Incorporate

JUPITER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND)

Citigroup analyst Yigal Nochomovitz reinstates Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy an

Wall Street analysts are making bold moves on Tuesday, shaking up ratings for some of the biggest na

RBC Capital analyst Douglas Miehm maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperfor

Agenus Inc. (AGEN) stock experiences profit-taking on Tuesday after a 111% surge. Discover the lates

EMERYVILLE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation today announced that

Acquisition adds seven  commercial products including VABYSMO® (faricimab-svoa), OJEMDA™ (tovorafeni

Agenus ($AGEN) stock rockets over 111% following stellar 3-year colorectal cancer data and a $340M f

The S&P 500 is up 10.3% YTD, and Wall Street is convinced the markets have more room to run, particu

B of A Securities analyst Jason Zemansky maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Bu

Stifel analyst Annabel Samimy maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and raise

Ligand Pharmaceuticals has delivered exceptional long-term returns, rising from ~$86 to nearly $300

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the pro

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the pro

Opportunistic capital raise with proceeds used to enhance financial flexibility  A portion of the pr

Kozarich sold 2,501 common shares. This transaction represented 5.65% of direct holdings.

JUPITER, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND)

5,000 shares were sold for a total transaction value of ~$1.14 million on June 1, 2026, at a weighte

JUPITER, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) t

Ligand Pharmaceuticals Incorporated will acquire XOMA Royalty Corporation for $39.00 per share in ca

Ligand Pharmaceuticals NASDAQ: LGND reported first-quarter 2026 results that management said reflect

First quarter performance driven by strong year-over-year royalty revenue growth of  56% Reaffirms P

U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acq

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

  On Friday, 1043 companies hit new 52-week lows.

    This morning 533 companies reached new 52-week highs.

    On Tuesday, 596 companies set new 52-week highs.

    Monday morning saw 558 companies set new 52-week highs.

  Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 30)

Stocks That Hit 52-Week Lows On Thursday

Benzinga's Top Upgrades, Downgrades For November 20, 2017